Rigel Pharmaceuticals, Inc. (RIGL) Posts Q2 Loss of 26c/Share
Get Alerts RIGL Hot Sheet
Price: $1.49 --0%
EPS Growth %: +50.0%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
SHIM, KOD, HEWA, More
EPS Growth %: +50.0%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q2 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $1.4 million versus the consensus estimate of $530 thousand.
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Recruit Holdings Co., Ltd (6098:JP) (RCRUY) PT Raised to JPY7,800 at Jefferies, 'emerged stronger since the last earnings season'
- Kodiak Sciences Inc. (KOD) Misses Q4 EPS by 36c
- Shimmick Corporation (SHIM) Misses Q4 EPS by 38c ; Provides Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!